Active Spectrum
Active Spectrum produces the world's smallest electron spin resonance (ESR/EPR) spectrometer, called Micro-ESR. Applications of Micro-ESR include analysis of antioxidants, lubricants, crude oil, catalysts, biodiesel stability, shelf life of vegetable oil, beer and wine, spin trapping and countless other uses.
Grantee: Alex Slocum
Arch Therapeutics
Fast safe hemostasis in the operating room and beyond.
Grantee: Rutledge Ellis-Behnke
Brontes Technologies, Inc. (3M)
The Lava Chairside Oral Scanner. uses proprietary "3D in Motion" technology to capture continuous 3D video images that create a digital impression used to produce precise-fitting restorations, delivering greater patient comfort and eliminating several time-consuming steps in both the dental office and laboratory. The device combines revolutionary hardware design, high-speed image processing algorithms and real-time modeling software, allowing doctors to instantaneously view the images on a touch screen monitor and review their work while the patient is still in the chair.
Grantee: Douglas Hart
Electrolytic Research Corporation
Environmentally friendly production of Titanium.
Grantee: Donald Sadoway
Firefly BioWorks
Firefly BioWorks is introducing an open platform that will allow industrial, academic, and clinical scientists to develop and use multiplexed assays on standard laboratory instrumentation. Their mission is to develop reliable and affordable solutions for the comprehensive monitoring of biological function.
Grantee: Patrick Doyle
Goby
A search engine which allows users to quickly and easily find fun activities in their locale or fill their next vacation itinerary.
Grantee: Michael Stonebraker
Hepregen Corporation
Hepregen Corporation is developing bioengineered solutions for drug development, including a platform for advanced toxicity screening and drug discovery. With its high fidelity model of the human liver, Hepregen's bioengineered solution may provide improved predictivity of how drugs will affect the liver once in humans.
Grantee: Sangeeta Bhatia
i2Chem Inc.
i2Chem synthesizes pharmaceuticals and fine chemicals using continuous flow reaction systems. These flow systems are a major advance over traditional “batch” systems providing more efficient , less costly and safer chemical processes from lab scale to production.
Grantee: Klavs Jensen
Lantos Technologies
Born in the labs of Professor Douglas Hart, MIT’s Mechanical Engineering department, a unique 3D scanning technology stands to revolutionize all things custom made for ears. Lantos Technologies, is working to commercialize 3D digital scanner capable of measuring ear canal shape and tissue compliance. This method will eliminate the uncertainties associated with manual fits, greatly improving the performance of custom made ear products. In addition to medical applications, there is the huge untapped market for mass customization of earphones at the retail point of sale..
Grantee: Douglas Hart
Liquid Metal Battery Corporation
LMBC is commercializing liquid metal battery technology for grid-scale energy storage.
Grantee: Don Sadoway
Molecular Stamping
The activity of Molecular Stamping is based on a novel printing technology called Supramolecular NanoStamping (SuNS),. SuNS is a flexible process for patterning biological molecules onto a substrate with very high resolution.
Grantee: Francesco Stellacci
Myomo, Inc.
Myomo® is pioneering NeuroRobotics™, a new category of non-invasive medical device technology to help people relearn how to move severely weak or partially paralyzed limbs.
Grantee: Woodie Flowers
Pervasis Therapeutics
Pervasis Therapeutics, Inc. is developing biologically active therapeutics to address complex diseases and unmet medical needs. With this objective, the company has developed technologies to regulate vascular repair and restore blood flow to critical organs and vasculature. The flagship product, Vascugel®, which has undergone two Phase II clinical trials, is a cell-based therapeutic matrix developed to reestablish healthy vasculature after vascular injury. Vascugel® has the capability to be delivered in both open surgical and minimally invasive procedures.
Grantee: Robert Langer
QD Vision
QD Vision, Inc. is a nanotechnology product company delivering a new generation of display and lighting solutions to major industries where color, power and design matter. QD Vision's Quantum Light™ platform, based on quantum dot technology, will deliver unparalleled color and brightness and require less power than current-generation LED technologies for consumer electronics products, flat-panel displays, electronic signage, solid-state lighting, and national security applications.
Grantee: Vladimir Bulovic
SpringLeaf Therapeutics
SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf's technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics.
Grantee: Yet-Ming Chiang
Taris Biomedical
TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products. The TARIS core technology and development efforts are being applied to disease areas with high unmet medical need in which current therapies or systemic treatments have failed. TARIS Biomedical has several drug-device convergence program opportunities focused on addressing those underserved disease areas through local delivery of therapeutics, with an initial focus on bladder diseases including Interstitial Cystitis (IC)/Painful Bladder Syndrome (PBS).
Grantee: Michael Cima
1366 Technologies
Solar at the cost of coal. 1366 Technologies is implementing a series of important manufacturing innovations to reduce the cost of silicon solar cell production and to improve the efficiency of these cells.
Grantee: Emanuel Sachs
Verayo, Inc.
Verayo is bringing to market a range of security and authentication solutions based on a breakthrough technology called Physical Unclonable Functions (PUFs). PUFs bring three fundamental capabilities to semiconductor ICs: PUFs make ICs effectively unclonable, PUFs make it possible to securely authenticate any IC, and PUFs can generate virtually unlimited number of unique cryptographic root master keys from each IC.
Verayo is harnessing PUFs to bring the following 4 solutions to market: Unclonable PUF-based ICs (RFIDs initially) for anti-counterfeiting, Modular Authentication Software solutions to authenticate PUF-based ICs, PUF based Crypto platforms for secure authentication & transaction processing, and Secure Processors for general purpose "trusted computing" applications.
Grantee: Srini Devadas
Vertica Systems
Vertica Analytic Database is a blazing-fast data warehousing software solution that runs on standard hardware.
Grantee: Michael Stonebraker
|
